sabato, 25 marzo 2023
20 Febbraio 2018

ASCO and NCCN Provide Guidelines for Managing Immunotherapy Side Effects

February 15, 2018 – Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body’s immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission. Patients who receive immune checkpoint inhibitors, however, may experience a unique set of side effects. These side effects can … (leggi tutto)